Patent · US Active

Process for the manufacture of an intermediate in the synthesis of dabigatran

US8378113B2 · kind B2 · utility

3Cited by

0References

6Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Ingo Heddesheimer · Monzingen, DE
Ulrich Scholz · Bad Hersfeld, DE

Key dates

Filing date	Jun 12, 2009
Grant date	Feb 19, 2013
Priority date	—
Expiry date	Dec 24, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D213/75
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to a process for the synthesis of the diamine of formula (1) an important intermediate in the synthesis of dabiagtran etexilate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.